Alvotech reported $586M of revenue over the trailing twelve months, +1494% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $586M (to FY2025). Net Income: $28M, trailing twelve months to FY2025. Free Cash Flow: −$115M, trailing twelve months to FY2025. Op Margin: 13%, trailing twelve months to FY2025.

ALVOAlvotech

HealthcareUSD

$4.91

$3.0052 weeks$9.00

ALVO as reported

Alvotech reported $586M of revenue over the trailing twelve months, +1494% on the year before. 10 reported series are charted on this page, each one as filed.

$586M

Revenue, trailing twelve months · to FY2025 · +1494% against the twelve months before

Net Income: $28M
Net Income · −128% year on year · trailing twelve months to FY2025
Free Cash Flow: −$115M
Free Cash Flow · −54% year on year · trailing twelve months to FY2025
Op Margin: 13%
Op Margin · trailing twelve months to FY2025

Every series Ryufin has for ALVO, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$586M	+1494%	FY2025
Net Income	$28M	−128%	FY2025
EPS	$0.10	−111%	FY2025
Gross Margin	60%	n/a	FY2025
Op Margin	13%	n/a	FY2025
Net Margin	4.8%	n/a	FY2025
ROE	−9.8%	n/a	FY2025
ROA	1.9%	n/a	FY2025
ROIC	7.3%	n/a	FY2025
Free Cash Flow	−$115M	−54%	FY2025